Vol. 11 No. 1: January-December 2024

Published: 2024-12-31

Full Issue

Vol. 11, January-December 2024

Original Research Articles

The economic burden of post-endoscopic retrograde cholangiopancreatography (ERCP) procedure infections in Italy

Paolo Sciattella, Annarosa Fornero, Susanna Marzia Adele Giordano, Claudio Giovanni De Angelis, Francesco Cattel

258-264

DOI: https://doi.org/10.33393/grhta.2024.3186
- PDF
- ePub
- HTML
Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage IV Hodgkin lymphoma in Italy

Chiara Bini, Andrea Marcellusi, Francesco Saverio Mennini, Silvia Ripoli, Laura Fioravanti, Victoria Federico Paly, Alexa Molinari, Paolo Morelli, Stanimira Krotneva, Shujun Li

248-257

DOI: https://doi.org/10.33393/grhta.2024.3167
- PDF
- ePub
- HTML
A 1-year per-patient cost of therapy administration analysis of mosunetuzumab and tisagenlecleucel in relapsed or refractory follicular lymphoma patients receiving two or more lines of systemic therapy

Marco Bellone, Alice Sabinot, Alessandro D’Arpino, Emanuela Omodeo Salè, Daniela Ghislieri, Lorenzo Pradelli

239-247

DOI: https://doi.org/10.33393/grhta.2024.3170
- PDF
- ePub
- HTML
Economic impact of dapagliflozin in the management of chronic kidney disease in Italy: results from a micro-simulation model

Roberto Ravasio, Andrea Marcellusi, Luca De Nicola

231-238

DOI: https://doi.org/10.33393/grhta.2024.3309
- PDF
- ePub
- HTML
Policy predictive model for better management of chronic obstructive pulmonary disease: economic-organisational implications in the Italian healthcare system

Debora Antonini, Fausto De Michele, Claudio Micheletto, Dejan Radovanovic, Michele Basile, Eugenio Di Brino, Agostino Fortunato, Valentina Donati, Filippo Rumi

223-230

DOI: https://doi.org/10.33393/grhta.2024.3114
- PDF
- ePub
- HTML
A cost-effectiveness analysis of Navina Smart on adult patients affected by neurogenic bowel dysfunction

Matteo Ruggeri, Alessandro Signorini, Silvia Caravaggio, Gabriele Righi

214-222

DOI: https://doi.org/10.33393/grhta.2024.3168
- PDF
- ePub
- HTML
Survival, treatment duration and costs of patients with prostate cancer treated with triptorelin in Italy: a study of administrative databases

Orazio Caffo, Gaetano Facchini, Luca Degli Esposti, Valentina Acciai, Giorgio Mauri, Paola Mazzanti, Giuseppe Fornarini

207-213

DOI: https://doi.org/10.33393/grhta.2024.3055
- PDF
- ePub
- HTML
The economic and social burden of congenital thrombotic thrombocytopenic purpura (cTTP) in Italy

Filippo Rumi, Michele Basile, Eugenio Di Brino, Agostino Fortunato, Debora Antonini

200-206

DOI: https://doi.org/10.33393/grhta.2024.3147
- PDF
- ePub
- HTML
Drug utilization and medication adherence for the treatment of psoriatic arthritis: an Italian study

Fiorenzo Santoleri, Paolo Abrate, Laura Pestrin, Enrico Pasut, Germana Modesti, Felice Musicco, Chiara Fulgenzio, Eva Zuzolo, Gabriella Pieri, Martina Roperti, Pietro Gazzola, Marco Gambera, Isabella Martignoni, Valentina Montresor, Francesca Guarino, Laura Grossi, Letizia Di Fabio, Cristina Roberti, Concetta Spoltore, Gabriella Tinari, Stefania De Rosa, Romina Giannini, Roberto Langella, Grazia Mingolla, Mariantonietta Piccoli, Alberto Costantini

191-199

DOI: https://doi.org/10.33393/grhta.2024.3204
- PDF
- ePub
- HTML
Budget impact analysis on the Italian healthcare system of roxadustat for the treatment of anemia due to chronic kidney disease

Chiara Bini, Andrea Marcellusi, Paolo Di Rienzo, Lucia Del Vecchio

175-190

DOI: https://doi.org/10.33393/grhta.2024.3062
- PDF
- ePub
- HTML
Assessment of innovativeness, and price and reimbursement negotiation of medicines: recommendations of an expert panel

Claudio Jommi, Francesca Patarnello, Cosetta Bianchi, Giuliano Buzzetti

169-174

DOI: https://doi.org/10.33393/grhta.2024.3107
- PDF
- ePub
- HTML
Exploring the administrative burden faced by hematologists: a comprehensive study in Italy

Davide Petruzzelli, Marco Vignetti, Stefania Trasarti, Paolo Sportoletti, Silvia Della Torre, Roberto Cairoli, Francesca Pia Chiara Leone, Giuseppe Pompilio, Marco Gullì, Eva Brown Hajdukova, Davide Integlia

161-168

DOI: https://doi.org/10.33393/grhta.2024.3042
- PDF
- epub
- HTML
Cabozantinib use in second or subsequent line of treatment in renal cell carcinoma: an analysis of Italian administrative databases

Cristian Lolli, Antonio Verde, Luca Degli Esposti, Valentina Acciai, Alessia Brigido, Emanuela Proietti, Sarah Scagliarini

154-160

DOI: https://doi.org/10.33393/grhta.2024.2892
- PDF
- ePUB
- HTML
Gender differences and hypercholesterolemia: real-world evidence from the study WECARE (Women Effective CArdiovascular Risk Evaluation)

Valentina Perrone, Gerardo Medea, Stefano Urbinati, Diego Sangiorgi, Luca Degli Esposti

138-147

DOI: https://doi.org/10.33393/grhta.2024.2731
- PDF
- ePUB
- HTML
How effective are prescriptive governance tools? Results from the application of AIFA notes

Giaele Moretti, Benedetta Dal Canto, Francesco Attanasio, Alma Martelli, Francesca Ferrè

131-137

DOI: https://doi.org/10.33393/grhta.2024.3027
- PDF
- ePUB
- HTML
Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders

María Reyes Abad, Carmen Alerany, Laia Alsina, Eduardo López Granados, Olaf Neth, José Luis Poveda, Jacques G. Rivière, Carlos Rodríguez-Gallego, Joanne B. Tutein Nolthenius, Raquel Figueiredo , Silvia Subías Labazuy , Alicia Gil

124-130

DOI: https://doi.org/10.33393/grhta.2024.3041
- PDF
- ePUB
- HTML
The economic impact of 14 compassionate use programs for medicines in Italy, in the perspective of the National Health Service

Claudio Jommi, Federico Pantellini, Giovanni Giuliani, Marianna Cavazza

115-123

DOI: https://doi.org/10.33393/grhta.2024.2735
- PDF
- ePUB
- HTML
Regional administrative data and their role in planning, programming and controlling at regional level

Irene Marzona, Paolo Stella, Gianluca Trifirò, Giovanni Corrao

101-104

DOI: https://doi.org/10.33393/grhta.2024.3024
- PDF
- ePUB
- HTML
Heart failure and economic impact: an analysis in real clinical practice in Italy

Melania Dovizio, Melania Leogrande, Luca Degli Esposti

94-100

DOI: https://doi.org/10.33393/grhta.2024.3013
- PDF
- ePUB
- HTML
The socioeconomic burden of adult attention-deficit/hyperactivity disorder in Spain

Maria Merino, Paulina Maravilla-Herrera, Teresa Martín Lorenzo, Juan Antonio Arance, Julio Bobes, Montse Corrales, Fátima Guzmán, María Morales, Carlos Mur

82-93

DOI: https://doi.org/10.33393/grhta.2024.2697
- PDF
- ePUB
- html
Regional Formularies in Italy: current state and future perspectives

Alberto Bortolami, Claudio Jommi, Filippo Bresciani, Luca Piccoli, Elisa Sangiorgi, Giovanna Scroccaro

68-74

DOI: https://doi.org/10.33393/grhta.2024.2677
- PDF
- html
- ePub
Cost per Number Needed to Treat (NNT) for upadacitinib in the treatment of bio-exposed patients with moderately-severely active ulcerative rectocolitis

Flavio Caprioli, Massimo Claudio Fantini, Francesca Marando, Dario Scaduto, Roberto Ravasio

55-67

DOI: https://doi.org/10.33393/grhta.2024.2658
- PDF
- ePUB
- HTML
Cost per NNT for upadacitinib in the treatment of patients with moderate-severe atopic dermatitis in Italy

Andrea Chiricozzi, Antonio Costanzo, Anna Levi, Federica Parretta, Roberto Ravasio

38-50

DOI: https://doi.org/10.33393/grhta.2024.2728
- PDF
- ePUB
- HTML
Clinical and economic burden of peristomal skin complications: Activity Based Costing analysis

Agostino Fortunato, Filippo Rumi, Massimo Zazzetta, Marco Della Valle, Vincenzo Pedace, Americo Cicchetti

31-37

DOI: https://doi.org/10.33393/grhta.2024.2639
- PDF
- ePUB
- html
Italian healthcare resource consumption for patients on hemodialysis treated for chronic kidney disease-associated pruritus (CKD-aP)

Silvia Calabria, Manenti Lucio, Giulia Ronconi, Carlo Piccinni, Leonardo Dondi, Letizia Dondi, Antonella Pedrini, Immacolata Esposito, Alice Addesi, Filippo Aucella, Nello Martini

22-30

DOI: https://doi.org/10.33393/grhta.2024.2696
- PDF
- ePuB
- html
A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas

Michele Basile, Ilaria Valentini, Roberto Attanasio, Renato Cozzi, Agnese Persichetti, Irene Samperi, Alessandro Scoppola, Renata Simona Auriemma, Ernesto De Menis, Felice Esposito, Emanuele Ferrante, Giuseppe Iatì, Diego Mazzatenta, Maurizio Poggi, Roberta Rudà, Fabio Tortora, Fabio Cruciani, Zuzana Mitrova, Rosella Saulle, Simona Vecchi, Paolo Cappabianca, Agostino Paoletta, Alessandro Bozzao, Marco Caputo, Francesco Doglietto, Francesco Ferraù, Andrea Gerardo Lania, Stefano Laureti, Stefano Lello, Davide Locatelli, Pietro Maffei, Giuseppe Minniti, Alessandro Peri, Chiara Ruini, Fabio Settanni, Antonio Silvani, Nadia Veronese, Franco Grimaldi, Enrico Papini, Americo Cicchetti

1-16

DOI: https://doi.org/10.33393/grhta.2024.2601
- ePUB
- PDF
- HTML

Point of View

Early access programs for medicines: a reform proposal for the Italian National Health Service

Patrizia Popoli, Giovanni Giuliani, Arturo Cavaliere, Claudio Jommi

148-153

DOI: https://doi.org/10.33393/grhta.2024.3098
- PDF
- ePUB
- HTML
The role and impact of health economics in the optimization of patient care in osteoarthritis: insights from a practical example

Mickaël Hiligsmann, Olivier Bruyère

75-81

DOI: https://doi.org/10.33393/grhta.2024.2682
- PDF
- ePUB
- html
HTA regulation: how is Italy moving?

Francesca Patarnello

51-54

DOI: https://doi.org/10.33393/grhta.2024.3025
- PDF
- ePUB
- HTML
The future of drugs distribution in the National Health System

Massimo Medaglia, Giuliano Buzzetti, Marco Cossolo, Paola Deambrosis, Giovanna Scroccaro

17-21

DOI: https://doi.org/10.33393/grhta.2024.2619
- PDF
- ePUB
- HTML

Short Communication

Patient-reported outcomes in epilepsy: a case study exploring their usage and impact

Simona Lattanzi, Angela La Neve

108-114

DOI: https://doi.org/10.33393/grhta.2024.3020
- PDF
- ePUB
- HTML
Costs and benefits in patients with NYHA class III heart failure treated with CardioMEMS in Italy

Andrea Messori, Maria Rita Romeo, Valeria Fadda, Francesca Collini, Sabrina Trippoli

105-107

DOI: https://doi.org/10.33393/grhta.2024.3018
- PDF
- ePUB
- HTML

Vol. 11 No. 1: January-December 2024

Full Issue

Original Research Articles

The economic burden of post-endoscopic retrograde cholangiopancreatography (ERCP) procedure infections in Italy

Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage IV Hodgkin lymphoma in Italy

A 1-year per-patient cost of therapy administration analysis of mosunetuzumab and tisagenlecleucel in relapsed or refractory follicular lymphoma patients receiving two or more lines of systemic therapy

Economic impact of dapagliflozin in the management of chronic kidney disease in Italy: results from a micro-simulation model

Policy predictive model for better management of chronic obstructive pulmonary disease: economic-organisational implications in the Italian healthcare system

A cost-effectiveness analysis of Navina Smart on adult patients affected by neurogenic bowel dysfunction

Survival, treatment duration and costs of patients with prostate cancer treated with triptorelin in Italy: a study of administrative databases

The economic and social burden of congenital thrombotic thrombocytopenic purpura (cTTP) in Italy

Drug utilization and medication adherence for the treatment of psoriatic arthritis: an Italian study

Budget impact analysis on the Italian healthcare system of roxadustat for the treatment of anemia due to chronic kidney disease

Assessment of innovativeness, and price and reimbursement negotiation of medicines: recommendations of an expert panel

Exploring the administrative burden faced by hematologists: a comprehensive study in Italy

Cabozantinib use in second or subsequent line of treatment in renal cell carcinoma: an analysis of Italian administrative databases

Gender differences and hypercholesterolemia: real-world evidence from the study WECARE (Women Effective CArdiovascular Risk Evaluation)

How effective are prescriptive governance tools? Results from the application of AIFA notes

Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders

The economic impact of 14 compassionate use programs for medicines in Italy, in the perspective of the National Health Service

Regional administrative data and their role in planning, programming and controlling at regional level

Heart failure and economic impact: an analysis in real clinical practice in Italy

The socioeconomic burden of adult attention-deficit/hyperactivity disorder in Spain

Regional Formularies in Italy: current state and future perspectives

Cost per Number Needed to Treat (NNT) for upadacitinib in the treatment of bio-exposed patients with moderately-severely active ulcerative rectocolitis

Cost per NNT for upadacitinib in the treatment of patients with moderate-severe atopic dermatitis in Italy

Clinical and economic burden of peristomal skin complications: Activity Based Costing analysis

Italian healthcare resource consumption for patients on hemodialysis treated for chronic kidney disease-associated pruritus (CKD-aP)

A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas

Point of View

Early access programs for medicines: a reform proposal for the Italian National Health Service

The role and impact of health economics in the optimization of patient care in osteoarthritis: insights from a practical example

HTA regulation: how is Italy moving?

The future of drugs distribution in the National Health System

Short Communication

Patient-reported outcomes in epilepsy: a case study exploring their usage and impact

Costs and benefits in patients with NYHA class III heart failure treated with CardioMEMS in Italy

Browse

banners150

Vol. 11 No. 1: January-December 2024

Full Issue

Original Research Articles

Point of View

Short Communication

Sign up

Browse

banners150